Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Current Opinion in Rheumatology
|
September 14, 2001
Infectious agents in chronic rheumatic diseases
K L Hyrich, R D Inman
Rheumatology (Oxford, England)
|
May 18, 2006
Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
K L Hyrich, K D Watson, A J Silman, et al.
Annals of the Rheumatic Diseases
|
July 10, 2004
Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety
K L Hyrich, A J Silman, K D Watson, et al.
Annals of the Rheumatic Diseases
|
May 7, 2010
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
W G Dixon, K L Hyrich, K D Watson, et al.
Rheumatology (Oxford, England)
|
April 19, 2008
Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
K L Hyrich, M Lunt, W G Dixon, et al.
Arthritis and Rheumatism
|
July 27, 2006
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
W G Dixon, K Watson, M Lunt, et al.
Arthritis Care & Research
|
June 11, 2010
Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register
W G Dixon, K D Watson, M Lunt, et al.
Arthritis and Rheumatism
|
September 1, 2007
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register
W G Dixon, K D Watson, M Lunt, et al.
Arthritis and Rheumatism
|
September 1, 2007
Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies
W G Dixon, D P M Symmons, M Lunt, et al.
Annals of the Rheumatic Diseases
|
October 27, 2009
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
W G Dixon, K L Hyrich, K D Watson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Current Opinion in Rheumatology
|
September 14, 2001
Infectious agents in chronic rheumatic diseases
K L Hyrich, R D Inman
Rheumatology (Oxford, England)
|
May 18, 2006
Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
K L Hyrich, K D Watson, A J Silman, et al.
Annals of the Rheumatic Diseases
|
July 10, 2004
Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety
K L Hyrich, A J Silman, K D Watson, et al.
Annals of the Rheumatic Diseases
|
May 7, 2010
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
W G Dixon, K L Hyrich, K D Watson, et al.
Rheumatology (Oxford, England)
|
April 19, 2008
Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
K L Hyrich, M Lunt, W G Dixon, et al.
Arthritis and Rheumatism
|
July 27, 2006
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
W G Dixon, K Watson, M Lunt, et al.
Arthritis Care & Research
|
June 11, 2010
Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register
W G Dixon, K D Watson, M Lunt, et al.
Arthritis and Rheumatism
|
September 1, 2007
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register
W G Dixon, K D Watson, M Lunt, et al.
Arthritis and Rheumatism
|
September 1, 2007
Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies
W G Dixon, D P M Symmons, M Lunt, et al.
Annals of the Rheumatic Diseases
|
October 27, 2009
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
W G Dixon, K L Hyrich, K D Watson, et al.
Page
of 2